Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Disorders of Hemostasis01:24

Disorders of Hemostasis

963
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
963
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

11
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
11
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

12
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
12
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

723
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
723

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concizumab in patients with hemophilia A or B without inhibitors: 56-week cut-off results of the phase 3 explorer8 study.

Blood advances·2026
Same author

Hypertension and blood pressure profiles in patients with acute intermittent porphyria: a prospective case-control study.

European journal of internal medicine·2026
Same author

Distinct Association of MRE11 and ATM Co-Expression with Clinical Outcomes in Laryngeal Cancer.

Oncology·2026
Same author

Prothrombotic Tendency in the Shadow of Cancer: Hypercoagulability, Impaired Clot Contraction and Fibrinolysis in Colorectal Cancer and Gastric Cancer Patients Undergoing Chemotherapy.

International journal of molecular sciences·2026
Same author

Thrombocytosis in cancer patients: when more is not better-in fact, the opposite.

Cancer metastasis reviews·2026
Same author

Impact of Baseline Body Mass Index on Immunotherapy Outcomes in Patients With Non-small-cell Lung Cancer.

Anticancer research·2025

Related Experiment Video

Updated: Jul 13, 2025

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

2.4K

In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale.

Marek Z Wojtukiewicz1,2, Petra Tesarova3, Debora Karetová4

  • 1Department of Oncology, Medical University of Bialystok, Bialystok, Poland.

Seminars in Thrombosis and Hemostasis
|October 18, 2023
PubMed
Summary

Managing thrombosis and bleeding in cancer patients is vital. New risk factors are emerging, necessitating improved cancer scales for better prediction and patient care.

More Related Videos

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.8K
Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research
07:26

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research

Published on: September 15, 2023

1.7K

Related Experiment Videos

Last Updated: Jul 13, 2025

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

2.4K
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.8K
Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research
07:26

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research

Published on: September 15, 2023

1.7K

Area of Science:

  • Oncology
  • Hematology
  • Clinical Medicine

Background:

  • Thrombosis and bleeding are frequent complications in cancer patients, impacting outcomes.
  • Current cancer assessment scales have limited ability to predict these specific events.
  • Advances in cancer understanding reveal new risk factors for thrombosis and bleeding.

Purpose of the Study:

  • To review current literature on cancer-associated thrombosis and bleeding.
  • To identify novel risk factors not captured by existing cancer scales.
  • To highlight the need for specialized scales for managing these complications.

Main Methods:

  • Literature analysis of current research on cancer-associated thrombosis and bleeding.
  • Identification and comparison of risk factors within existing and novel scales.
  • Assessment of the limitations of current cancer scales in predicting thrombotic and bleeding events.

Main Results:

  • Existing cancer scales offer partial insights but are insufficient for precise risk stratification of thrombosis and bleeding.
  • New risk factors for cancer-associated thrombosis and bleeding are continually being identified.
  • There is a clear need for more specific and accurate scales tailored to these complications.

Conclusions:

  • Current cancer scales require enhancement or replacement with specialized tools for better risk assessment of thrombosis and bleeding.
  • Developing novel cancer scales focused on thrombosis and bleeding is crucial for optimizing patient management and outcomes.
  • Improved risk stratification will lead to more targeted prophylactic and therapeutic strategies, reducing mortality and recurrence while minimizing bleeding risk.